JHL 1188 (trastuzumab biosimilar) / Eden Biologics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
JHL 1188 (trastuzumab biosimilar) / Eden Biologics
ACTRN12618001597280: A Study to Compare the Pharmacokinetics, Safety, Tolerability and Immunogenicity of JHL1188 versus Herceptin (EU and US sourced) in Healthy Male subjects

Withdrawn
1
159
 
JHL Biotech Australia Pty Ltd., JHL Biotech, Inc.
Breast Cancer
 
 

Download Options